Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA:688796)

Market Cap	28.54B +906.8%
Revenue (ttm)	1.19B +48.8%
Net Income	132.21M
EPS	0.33
Shares Out	n/a
PE Ratio	215.89
Forward PE	182.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,060,236
Average Volume	3,352,770
Open	72.22
Previous Close	72.83
Day's Range	70.19 - 73.28
52-Week Range	48.06 - 78.75
Beta	n/a
RSI	55.48
Earnings Date	Mar 26, 2026

About SHA:688796

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally. It operates through five segments: Gene-editing services, Pre-clinical pharmacology and efficacy evaluation, Animal models selling, Antibody development, and Innovative drugs development. The Gene-editing services segment provides the customized gene editing services based on animals as well as c...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2008
• Employees: 1,306
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688796